Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Medicines Committee

National Academy of Sciences-National Academy of Engineering-Institute of Medicine, Committee on Science, Engineering, and Public Policy. "Report of the Research Briefing Panel on Chemical and Process Engineering for Biotechnology," in Research Briefings 1984. Washington, D.C. National Academy Press, 1984. [Pg.47]

Staff Institute of Medicine Committee Dietary Reference intakes. Review of Dietary Anhtovns, National Academy Press. Washington, T)C, 1999... [Pg.141]

Support for this project was provided by U.S. Food and Drug Administration Contract No. 223-99-2321. The views presented in this report are those of the Institute of Medicine Committee on Food Chemicals Codex and are not necessarily those of the funding agency. [Pg.1000]

Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm. Washington, DC National Academy Press, 2001. [Pg.486]

Dr. Veenema has served as a reviewer to the Institute of Medicine Committee on the Review Panel for the Smallpox Vaccination Implementation, Jane s Chem-Bio Handbook, 2nd Edition, and serves on the editorial board for the journal Disaster Management and Response, sponsored by the Emergency Nurses Association. Dr. Veenema is an Associate Editor for the Journal of Disaster Medicine and Public Health Preparedness, sponsored by the American Medical Association. [Pg.658]

Institute of Medicine, Committee to Survey the Health Effects of Mustard Gas and Lewisite, Division of Health Promotion and Disease Prevention. 1993. Veterans at Risk The Health Effects of Mustard Gas and Lewisite, C.M. Pechura and D.P. Rail, eds. National Academy Press, Washington, DC. [Pg.286]

The restructured Portuguese approvals advisory body, the Technical Medicines Committee (CTM) was established in June 1996 cind INFARMED expected that the increase in the number of committee members, which doubled to almost 60 would mean it could operate more quickly and efficiently, in line with EU requirements. However, the average approval time in Portugcil is still three to four years though INFARMED says that the average time for new products is less than one year while... [Pg.519]

Dr. Edwards chaired the PMA Special Population Committee, and also sat on the Institute of Medicine Committee for Research in Women, sponsored by the US National Instates of Health. He also served on the efficacy subcommittee Topic 5 (Acceptability of Foreign Clinical Data) for the International Committee on Harmonization (ICH). [Pg.775]

Institute of Medicine Committee on Assessing the System for Protecting Human Research Participants Report Preserving Public Trust Accreditation and Human Research Participant Protection Programs, 2001. [Pg.437]

New York Academy of Medicine, Committee on Public Health, Bull, N, Y. Acad. Med. 38,415 (1962). [Pg.19]

Institute of Medicine, Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program. Evaluation of the U.S. Department of Defense Persian Gulf Syndrome Comprehensive Clinical Evaluation Program, Committee on the DoD Persian Gulf Comprehensive Clinical Evaluation, National Academy Press, Washington, DC, 1996. [Pg.309]

Margit L. Bleecker is director of the Center for Occupational and Environmental Neurology in Baltimore, Maiyland. Her research interests are in clinical industrial neurotoxicology and occupational neurology. Dr. Bleecker was a member of the National Research Council Committee on Tetrachloroethylene and the Institute of Medicine Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides and Committee on the DOD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program. She received her PhD from the State University of New York Downstate Medical Center and her MD from the University of California, San Francisco, School of Medicine. Dr. Bleecker is certified by the American Board of Psychiatry and Neurology. [Pg.175]

Public Health and associate professor of medicine at Harvard Medical School. Her research interests are in neurotoxicity, metals, pediatric environmental health, and iimovative education in environmental and occupational medicine. Dr. Goldman was a member of two Institute of Medicine Committees on Gulf War and Health, which evaluated potential health effects of exposure to pesticides and Sarin, the National Research Council Committee on Handling and Disposal of Biohazards from the Laboratory, and the National Research Council Committee to Review the 0MB Risk Assessment Bulletin. She received her MD from the Yale University School of Medicine and her MS and MPH from the Harvard School of Public Health. Dr. Goldman is certified by the American Board of Internal Medicine and by the American Board of Preventive Medicine in occupational medicine. [Pg.176]

Based on an acceptable cost-benefit and risk-benefit-assessment for both public and individual health, a pharmacist is mandated for the legal provision of medicines used to treat his patients. This scope is defined by Acts, Ordinances or Decrees, national or regional needs, and, in hospitals, is formalised in the formulary, normally defined by a medicines committee. This formulary includes medicines, controlled medicines, devices, chemicals, disinfectants, and ethanol in various concentrations and presentations. Each pharmacy should be responsible for ensuring that a locally agreed list of products should be available to meet the needs of the business even in times of accidents and catastrophes (Table 3.1). This list is adapted and recalculated from a list of a Swiss University Hospital, which has been agreed by emergency and ICU, anaesthesia, and hospital pharmacy... [Pg.27]

AAAM, 1985. Abbreviated Injury Scale. American Association for Automotive Medicine, Committee on Injury Scale, Arlington Heights. [Pg.409]

EM A, European Agency for the Evaluation of Medicinal Products, Committee for Medicinal Products for Veterinary Use Summary Reports (human and animal exposures to veterinary medicines), Committee for Medicinal Products for Human Use opinions and assessment reports. [Pg.53]

Institute of Medicine, Committee on Quality of Health Care in America, To Err Is Human Building a Safer Health System, eds. Linda T. Kohn, Janet M. Corrigan, and Molla S. E>onaldson (Washington, DC National Academy Press, 1999). Viewed at www.nap.edu. [Pg.13]


See other pages where Medicines Committee is mentioned: [Pg.2179]    [Pg.210]    [Pg.287]    [Pg.245]    [Pg.35]    [Pg.1935]    [Pg.310]    [Pg.106]    [Pg.220]    [Pg.2885]    [Pg.2428]    [Pg.76]    [Pg.274]    [Pg.274]    [Pg.299]    [Pg.306]    [Pg.2409]    [Pg.2183]    [Pg.178]    [Pg.158]    [Pg.342]    [Pg.177]    [Pg.84]   
See also in sourсe #XX -- [ Pg.245 ]




SEARCH



CPMP (Committee for Proprietary Medicinal

Committee for Herbal Medicinal

Committee for Herbal Medicinal Products

Committee for Human Medicinal

Committee for Human Medicinal Products

Committee for Medicinal Products

Committee for Orphan Medicinal

Committee for Orphan Medicinal Products

Committee for Orphan Medicinal Products COMP)

Committee for Proprietary Medicinal

Committee for Proprietary Medicinal Products

Committee for Proprietary Medicinal Products (CPMP

Committee for Veterinary Medicinal

Committee for Veterinary Medicinal Products

Committee for Veterinary Medicinal Products CVMP)

Committee on Herbal Medicinal Products

Committee on Proprietary Medicinal

Committee on Proprietary Medicinal Products

Committee on Proprietary Medicinal Products CPMP)

Committee on Safety of Medicines

Committee on Safety of Medicines (CSM

Committee on Veterinary Medicinal Products

Committee on the Safety of Medicines

European Medicines Agency Committees

European Medicines Evaluation Agency Scientific Committees

Parliamentary Select Committee on Patent Medicines

Physicians Committee for Responsible Medicine

Scientific Committee on Medicinal

Scientific Committee on Medicinal Products and Medical

The Committee for Proprietary Medicinal Products,

© 2024 chempedia.info